Results 21 to 30 of about 3,759 (138)

Prurigo nodularis responding to intravenous immunoglobulins

Przegląd Dermatologiczny, 2022
Prurigo nodularis is a chronic skin disease, especially seen in middle-aged women adults. It is characterized by symmetric, pruritic hyperkeratotic nodules and papules on the extensor surfaces [1].
Koray Durmaz, Arzu Ataseven, Ilkay Ozer, Sıddıka Fındık   +3 more
doaj   +1 more source

Prurigo crónico: actualización

Actas Dermo-Sifiliográficas, 2022
Resumen: El prurigo crónico es una entidad con una apariencia clínica común pero que puede ser secundaria a un gran número de patologías. Históricamente ha sido una enfermedad no bien definida y con escasas terapias disponibles, por lo que su manejo es ...
A. Docampo-Simón, M.J. Sánchez-Pujol, J.F. Silvestre-Salvador   +2 more
doaj   +1 more source

Chronic Nodular Prurigo: A European Cross-sectional Study of Patient Perspectives on Therapeutic Goals and Satisfaction

Acta Dermato-Venereologica, 2021
Chronic nodular prurigo is characterized by recalcitrant itch. Patient perspectives on therapeutic goals, satisfaction with therapy and efficacy of therapeutic regimens for this condition are unknown. This questionnaire study examined these issues in 406
Manuel P. Pereira, Claudia Zeidler, Joanna Wallengren, Jon Anders Halvorsen, Elke Weisshaar, Simone Garcovich, Laurent Misery, Emilie Brenaut, Ekin Şavk, Nikolay Potekaev, Andrey Lvov, Svetlana Bobko, Jacek C. Szepietowski, Adam Reich, Agnieszka Bozek, Franz J. Legat, Martin Metz, Markus Streit, Esther Serra-Baldrich, Margarida Gonçalo, Michael Storck, Teresa Nau, Vincent Hoffmann, Sabine Steinke, Ina Greiwe, Martin Dugas, Matthias Augustin, Sonja Ständer   +27 more
doaj   +1 more source

Out‐of‐pocket expenditures in adult patients with prurigo nodularis in France

JEADV Clinical Practice, 2023
Background Chronic prurigo or prurigo nodularis is a severe condition with chronic pruritus and skin lesions. Current unnmet medical needs are numerous and generate a significant burden for the patients.
Laurent Misery, Christine Patras deCampaigno, Denis Jullien, Adrien Marquie, Sylvie Gabriel, Charles Taieb, Carle Paul   +6 more
doaj   +1 more source

Early-onset, severe prurigo nodularis in a young child with atopic dermatitis treated successfully with dupilumab

Indian Journal of Paediatric Dermatology, 2022
Prurigo nodularis is an extremely pruritic skin condition as a result of chronic and vicious cycle of itching and scratching. It is rare in children. We report a case of a 4-year-old child with a background of poorly controlled atopic dermatitis with ...
Henrietta Albela, Kin Fon Leong
doaj   +1 more source

TRPM8 Agonist (Cryosim-1) Cream for Chronic Prurigo: A Randomized, Vehicle-controlled Trial. [PDF]

Acta Derm Venereol
Chronic prurigo (CP) is a distressing dermatological condition lacking effective topical therapies. This randomized, double-blind, vehicle-controlled trial evaluated the efficacy and safety of Cryosim-1, a TRPM8 agonist cream, in 30 adults with CP ...
Um JY, Kim HB, Lee SY, Chung BY, Park CW, Kim HO.   +5 more
europepmc   +2 more sources

Oral Alitretinoin for Patients with Refractory Prurigo

Medicina, 2020
Background: prurigo is a chronic skin disorder associated with a history of chronic pruritus. The pathogenesis of prurigo is largely unknown and the treatment of prurigo is unsatisfactory and challenging.
Bo Young Chung, Ji Young Um, Seok Young Kang, Min Je Jung, Jin Cheol Kim, In-Suk Kwak, Chun Wook Park, Hye One Kim   +7 more
doaj   +1 more source

Analysis of 325 Patients with Chronic Nodular Prurigo: Clinics, Burden of Disease and Course of Treatment

Acta Dermato-Venereologica, 2020
Chronic nodular prurigo presents with multiple pruriginous nodules and severe pruritus. This study aims to explore the treatment course and regimens in patients with chronic nodular prurigo and to analyse predictive factors contributing to therapeutic ...
Sonja Gründel, Manuel P. Pereira, Michael Storck, Nani Osada, Gudrun Schneider, Sonja Ständer, Claudia Zeidler   +6 more
doaj   +1 more source

Dupilumab in Inflammatory Skin Diseases: A Systematic Review

Biomolecules, 2023
Dupilumab was first approved for the treatment of atopic dermatitis (AD) and blocks the signaling of interleukin (IL)-4 and -13. Several other chronic skin conditions share mechanistic overlaps with AD in their pathophysiology, i.e., are linked to type 2
Henning Olbrich, Christian D. Sadik, Ralf J. Ludwig, Diamant Thaçi, Katharina Boch   +4 more
doaj   +1 more source

Efficacy of anti‐immunoglobulin E therapy in patients with prurigo: A pilot study

Journal of Cutaneous Immunology and Allergy, 2019
Objectives Chronic prurigo is a reactive skin disease marked by multiple pruriginous lesions such as papules, nodules, and erythema. We previously showed that basophil infiltration into the pruriginous lesions and basophil activation in blood are ...
Tsukasa Ugajin, Hiroo Yokozeki
doaj   +1 more source